Intertek (Texas, USA) has opened a new chemical laboratory to support the growth of the growing refining and petrochemical complex in Texas City (Texas, USA).
Intertek (Texas, USA) has opened a new chemical laboratory to support the growth of the growing refining and petrochemical complex in Texas City (Texas, USA).
The new 9415 square foot laboratory and office maintains 24/7 operations to support local demand, with additional modern analytical instrumentation for troubleshooting, trace analysis, and quality control testing for feed-stocks and products including crude oil, refined fuels, and petrochemicals.
Michael Calais, Branch Manager for Intertek’s Texas City operations, said: “Intertek is proud to be the first development in a newly re-zoned industrial area of Texas City. We’ve been operating in Texas City for over 20 years, providing value and jobs to the area. The new laboratory complements Intertek’s significant laboratory network in Texas and the Houston region.”
For more information please visit:
www.intertek.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.